Cargando…

Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Review

It is well-established that tumor antigens and molecules expressed and secreted by cancer cells trigger innate and adaptive immune responses. These two types of anti-tumor immunity lead to the infiltration of the tumor’s microenvironment by immune cells with either regulatory or cytotoxic properties...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koukourakis, Ioannis M., Platoni, Kalliopi, Tiniakos, Dina, Kouloulias, Vassilis, Zygogianni, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216994/ https://www.ncbi.nlm.nih.gov/pubmed/37232754 http://dx.doi.org/10.3390/cimb45050285

Ejemplares similares

Prostate Cancer Stem Cells: Biology and Treatment Implications
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Craniospinal Irradiation: A Dosimetric Comparison Between O-Ring Linac and Conventional C-arm Linac
por: Stroubinis, Theodoros, et al.
Publicado: (2022)

Early Prediction of Planning Adaptation Requirement Indication Due to Volumetric Alterations in Head and Neck Cancer Radiotherapy: A Machine Learning Approach
por: Iliadou, Vasiliki, et al.
Publicado: (2022)

Surface-Guided Radiotherapy: Can We Move on from the Era of Three-Point Markers to the New Era of Thousands of Points?
por: Psarras, Michalis, et al.
Publicado: (2023)

Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer
por: Liu, Chao, et al.
Publicado: (2022)

The Treatment Outcome and Radiation-Induced Toxicity for Patients with Head and Neck Carcinoma in the IMRT Era: A Systematic Review with Dosimetric and Clinical Parameters
por: Kouloulias, Vassilis, et al.
Publicado: (2013)

Radio-Immunotherapy: A Case Report of ‘Abscopal Hyper-Progression’?
por: Koukourakis, Ioannis M, et al.
Publicado: (2020)

Radiation therapy for the prevention of heterotopic ossification: Efficacy and toxicity of single fraction radiotherapy
por: Georhakopoulos, Ioannis, et al.
Publicado: (2020)

Isodose surface differences: A novel tool for the comparison of dose distributions
por: Diamantopoulos, Stefanos, et al.
Publicado: (2023)

Anti-Tumor Immunity and Preoperative Radiovaccination: Emerging New Concepts in the Treatment of Breast Cancer
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Evaluation of acute/late toxicity and local recurrence in T1–T2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT)
por: Kouloulias, Vassilis E., et al.
Publicado: (2013)

An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma
por: Qian, Liwen, et al.
Publicado: (2022)

Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up
por: KOULOULIAS, V., et al.
Publicado: (2014)

Three-Dimensional Conformal Radiotherapy for Hepatocellular Carcinoma in Patients Unfit for Resection, Ablation, or Chemotherapy: A Retrospective Study
por: Kouloulias, Vassilis, et al.
Publicado: (2013)

Implementation, Dosimetric Assessment, and Treatment Validation of Knowledge-Based Planning (KBP) Models in VMAT Head and Neck Radiation Oncology
por: Fanou, Anna-Maria, et al.
Publicado: (2023)

Bone Density as a Marker of Response to Radiotherapy in Bone Metastatic Lesions: A Review of the Published Data
por: Kouloulias, Vassilis, et al.
Publicado: (2016)

Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023)

Stereotactic Arrhythmia Radioablation as a Novel Treatment Approach for Cardiac Arrhythmias: Facts and Limitations
por: Chalkia, Marina, et al.
Publicado: (2021)

Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy
por: Guan, Bingjie, et al.
Publicado: (2023)

Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
por: Kim, Eunji, et al.
Publicado: (2019)

Dosimetric comparison and evaluation of two computational algorithms in VMAT treatment plans
por: Tsimpoukelli, Maria, et al.
Publicado: (2023)

Single-cell genomics identifies immune response to neoadjuvant chemoradiotherapy
por: Sinha, Uttam K., et al.
Publicado: (2022)

From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC
por: Protopapa, Maria, et al.
Publicado: (2019)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
por: Molinari, Chiara, et al.
Publicado: (2011)

Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer
por: Filitto, Giuseppe, et al.
Publicado: (2022)

Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer
por: Veen, Torhild, et al.
Publicado: (2023)

An exercise trial for adults undergoing neoadjuvant chemoradiotherapy for rectal cancer proves not feasible: recommendations for future trials
por: Brunet, Jennifer, et al.
Publicado: (2021)

Quality of Life, Anxiety, and Depression in the Head-and-Neck Cancer Patients, Undergoing Intensity-Modulated Radiotherapy Treatment
por: Nikoloudi, Maria, et al.
Publicado: (2020)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Li, Yi, et al.
Publicado: (2016)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

Neoadjuvant FOLFIRINOX followed by Chemoradiotherapy for Middle and Lower Rectal Cancer
por: Sakr, Amr, et al.
Publicado: (2020)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
por: Huemer, Florian, et al.
Publicado: (2020)

Post-operative anastomotic leakage and collagen changes in patients with rectal cancer undergoing neoadjuvant chemotherapy vs chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022)

Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy or chemoradiotherapy in resectable esophageal cancer: A systematic review and meta-analysis
por: Wang, He, et al.
Publicado: (2022)

Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer
por: Giatromanolaki, Alexandra, et al.
Publicado: (2022)

MRI texture analysis in predicting treatment response to neoadjuvant chemoradiotherapy in rectal cancer
por: Meng, Yankai, et al.
Publicado: (2017)

Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Toomey, Sinead, et al.
Publicado: (2020)

Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy
por: Guo, Su-ping, et al.
Publicado: (2021)

Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
por: Zhang, Qi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7qtnak89nft58nengorprr6qf9